Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors including its parent company, and Google holding firm, Alphabet.
Google's life sciences arm Verily is keeping tight-lipped about its work, but a very ‘top-level’ presentation by its chief technical officer last week hinted that the firm has hit obstacles to
Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough